Agenus Inc.
Records under this name other than the patents Agenus Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 41 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,144,779 | ANTI-CTLA-4 Antibodies and Methods of Use Thereof Formerly held In force · High confidence | In force | High confidence | |
| US 10,323,091 | ANTI-PD-1 Antibodies and Methods of Use Thereof Formerly held In force · High confidence | In force | High confidence | |
| US 12,344,670 | ANTI-ILT4 Antibodies and Antigen-Binding Fragments Formerly held In force · High confidence | In force | High confidence | |
| US 11,053,315 | Anti-ILT4 Antibodies and Antigen-Binding Fragments Formerly held In force · High confidence | In force | High confidence | |
| US 12,391,741 | T Cell Receptors That Bind to Mixed Lineage Leukemia (MLL)-Specific Phosphopeptides and Methods of Use Thereof Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 11,897,957 | ANTI-ILT4 Antibodies and Antigen-Binding Fragments Formerly held In force · High confidence | In force | High confidence | |
| US 11,897,956 | ANTI-ILT4 Antibodies and Antigen-Binding Fragments Formerly held In force · High confidence | In force | High confidence | |
| US 11,613,764 | T Cell Receptors That Bind to NY-ESO-1 and Methods of Use Thereof Formerly held In force · High confidence | In force | High confidence | |
| US 11,013,802 | ANTI-CTLA-4 Antibodies and Methods of Use Thereof Formerly held In force · High confidence | In force | High confidence | |
| US 11,898,165 | Engineered Host Cells and Methods of Use Thereof Formerly held In force · High confidence | In force | High confidence |